- Home
- MGIC vs VCEL Comparison
MGIC vs VCEL Comparison
Compare MGIC & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- VCEL
- Stock Information
- Founded
- MGIC 1983
- VCEL 1989
- Country
- MGIC Israel
- VCEL United States
- Employees
- MGIC N/A
- VCEL N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGIC Technology
- VCEL Health Care
- Exchange
- MGIC Nasdaq
- VCEL Nasdaq
- Market Cap
- MGIC 788.0M
- VCEL 2.1B
- IPO Year
- MGIC 1991
- VCEL 1997
- Fundamental
- Price
- MGIC $20.80
- VCEL $38.02
- Analyst Decision
- MGIC Buy
- VCEL Strong Buy
- Analyst Count
- MGIC 2
- VCEL 8
- Target Price
- MGIC $16.00
- VCEL $62.00
- AVG Volume (30 Days)
- MGIC 95.6K
- VCEL 481.0K
- Earning Date
- MGIC 08-13-2025
- VCEL 07-31-2025
- Dividend Yield
- MGIC 2.70%
- VCEL N/A
- EPS Growth
- MGIC 1.33
- VCEL 521.85
- EPS
- MGIC 0.76
- VCEL 0.05
- Revenue
- MGIC $569,136,000.00
- VCEL $238,541,000.00
- Revenue This Year
- MGIC $7.53
- VCEL $23.03
- Revenue Next Year
- MGIC $8.96
- VCEL $24.52
- P/E Ratio
- MGIC $27.28
- VCEL $716.32
- Revenue Growth
- MGIC 6.37
- VCEL 14.80
- 52 Week Low
- MGIC $9.64
- VCEL $36.97
- 52 Week High
- MGIC $22.00
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- MGIC 70.18
- VCEL 36.65
- Support Level
- MGIC $20.50
- VCEL $39.39
- Resistance Level
- MGIC $22.00
- VCEL $42.61
- Average True Range (ATR)
- MGIC 0.55
- VCEL 1.59
- MACD
- MGIC 0.09
- VCEL -0.29
- Stochastic Oscillator
- MGIC 75.45
- VCEL 0.00
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.